|
|
Unrelated Donors |
| Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia |
753 |
| P Kalhs,
S Brugger,
E Reiter,
F Keil,
G Fischer,
A Schulenburg,
W Rabitsch,
A Rosenmayr,
K Dieckmann,
M Kurz,
I Schwarzinger,
B Volc-Platzer,
C Mannhalter,
K Lechner & HT Greinix
|
|
Abstract
Full Article (PDF)
|
|
Progenitor Cell Mobilization |
| Low incidence of human herpesvirus 8 in stem cell collections from myeloma patients |
759 |
| GM Cull,
GI Carter,
JM Timms,
BJ Thomson,
NH Russell & AP Haynes
|
|
Abstract
Full Article (PDF)
|
|
| Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer |
763 |
| H Wandt,
J Birkmann,
Th Denzel,
K Schäfer,
G Schwab,
D Pilz,
H Egger,
A Both & WM Gallmeier
|
|
Abstract
Full Article (PDF)
|
|
Graft-Versus-Leukaemia |
| Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation |
771 |
| AH Elmaagacli,
DW Beelen,
G Trenn,
O Schmidt,
M Nahler & UW Schaefer
|
|
Abstract
Full Article (PDF)
|
|
Immune Recovery |
| Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients |
779 |
| TH Eiermann,
P Lambrecht & AR Zander
|
|
Abstract
Full Article (PDF)
|
|
| Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count |
783 |
| E Bolotin,
G Annett,
R Parkman & K Weinberg
|
|
Abstract
Full Article (PDF)
|
|
Prognostic Factors |
| Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution |
789 |
| O Hartmann,
D Valteau-Couanet,
G Vassal,
V Lapierre,
L Brugières,
R Delgado,
D Couanet,
J Lumbroso & E Benhamou
|
|
Abstract
Full Article (PDF)
|
|
Miscellaneous Complications |
| Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration |
797 |
| J Trotman,
I Nivison-Smith & A Dodds
|
|
Abstract
Full Article (PDF)
|
|
| Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD) |
803 |
| S Kulkarni,
M Rodriguez,
A Lafuente,
P Mateos,
J Mehta,
S Singhal,
R Saso,
D Tait,
JG Treleaven & RL Powles
|
|
Abstract
Full Article (PDF)
|
|
Technical Reports |
| Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells |
809 |
| B Hoppe,
M Mohr,
A Roots-Weiß,
J Kienast & WE Berdel
|
|
Abstract
Full Article (PDF)
|
|
| Enrichment of peripheral blood CD34+ cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptide releasing agent |
819 |
| JP Marolleau,
L Dal Cortivo,
B Mills,
JP Fermand,
JM Miclea,
JP Lotz,
C Gisselbrecht & M Benbunan
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation |
827 |
| ASM Yong & JM Goldman
|
|
Abstract
Full Article (PDF)
|
|
| Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation |
829 |
| T Suzuki,
Y Saijo,
M Ebina,
M Yaekashiwa,
M Minegishi,
S Tsuchiya,
T Konno,
S Ono,
Y Matsumura,
S Fujimura & T Nukiwa
|
|
Abstract
Full Article (PDF)
|
|
| Successful non-invasive ventilatory support in a patient with regimen-related toxicity during allogeneic bone marrow transplantation |
833 |
| K Ghosh,
B Rafique,
J Tirkey,
E Benjamin,
S Jacob & J Goes
|
|
Abstract
Full Article (PDF)
|
|
| Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer |
835 |
| J Samuelsson,
H Zackrisson,
L Tokics,
P Ljungman,
E Lidbrink,
P Pircher & L Larsson
|
|
Abstract
Full Article (PDF)
|
|
| Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease |
839 |
| JJ Perry,
RA Fleming,
MV Rocco,
WP Petros,
AJ Bleyer,
JE Radford Jr,
BL Powell & DD Hurd
|
|
Abstract
Full Article (PDF)
|
|
| Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation |
843 |
| MM Abecasis,
JP Conceição Silva,
I Ferreira,
A Guimarães & A Machado
|
|
Abstract
Full Article (PDF)
|
|
| Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells? |
847 |
| M Yano,
A Watanabe,
Y Kawano,
T Watanabe & Y Takaue
|
|
Abstract
Full Article (PDF)
|
|
| Fludarabine-based preparative protocol for unrelated donor cord blood transplantation in children: successful engraftment with minimal toxicity |
849 |
| KW Chan,
AN Békássy,
CS Ha,
C Nunez,
TA Alvegård & B Sallerfors
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Contribution of maternal and neonatal factors to the evaluation of umbilical cord blood |
853 |
| I Prat,
MC Hernández,
M Ortiz,
A Flores,
R González de Gor,
F Sánchez,
E Terol,
A Galeote,
MD Ruiz,
J Larracoechea & J Maldonado
|
|
Full Article (PDF)
|
|
| Unusual presentation of cerebral toxoplasmosis after BMT |
855 |
| LF Bleggi-Torres,
BC de Medeiros,
B Werner,
R Pasquini & CR de Medeiros
|
|
Full Article (PDF)
|
|
| Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse |
857 |
J Moravcová,
S Muchová,
M Luká ová,
H Klamová,
J B ezinová & Z Gaová
|
|
Full Article (PDF)
|
|
